Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1,174,963
-
Shares change
-
-497,514
-
Total reported value, excl. options
-
$5,650,000
-
Value change
-
-$3,625,860
-
Number of buys
-
15
-
Number of sells
-
-9
-
Price
-
$4.81
Significant Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q2 2014
27 filings reported holding ADMP - ADAMIS PHARMACEUTICALS CORP - COM NEW as of Q2 2014.
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,174,963 shares
.
Largest 10 shareholders include GROW Partners, LLC (505,200 shares), BARD ASSOCIATES INC (176,075 shares), SCOGGIN LLC (87,718 shares), GOLDMAN SACHS GROUP INC (85,050 shares), Granite Point Capital Management, L.P. (83,700 shares), HighTower Advisors, LLC (66,000 shares), BlackRock Institutional Trust Company, N.A. (45,289 shares), GEODE CAPITAL MANAGEMENT, LLC (35,529 shares), NORTHERN TRUST CORP (23,276 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (17,040 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.